In partnership with The Alzheimer's Association Georgia Chapter

Thursday, September 19, 2024

6:00 PM – 6:30 PM Dinner/Registration
6:30 PM – 8:30 PM Meeting

Atlanta Marriott Buckhead
3405 Lenox Road NE
Atlanta, GA 30326
Meeting Room: Buckhead Ballroom (convention level)

PROGRAM FEATURES

• • Online personalized quality-improvement poster-generation portal
  • Downloadable whiteboard animations and case study video
  • DETECT Alzheimer’s website

PROGRAM OVERVIEW

This case-based educational activity is designed to help Alzheimer’s disease and dementia providers diagnose AD earlier in the disease course through comprehensive history, physical and quantitative assessments, neuroimaging, and referral when appropriate. Through interactive case-based learning, our faculty will assist learners in developing strategies to improve multidisciplinary and clinician/patient communication to facilitate the best possible treatment outcomes.

PRESENTING FACULTY

	Marc Agronin, MD Chief Medical Officer Frank C. and Lynn Scaduto MIND Institute and Behavioral Health Miami Jewish Health Miami, FL
	Monica W. Parker, MD Associate Professor of Medicine Department of Neurology Director, Outreach Recruitment and Education Core Director, Minority Engagement Core Goizueta Alzheimer's Disease Research Center  at Emory University Atlanta, GA

LEARNING OBJECTIVES

• Implement strategies to overcome barriers to timely diagnosis of Alzheimer’s disease, addressing stigma, applying quantitative assessments, and integrating neuroimaging as well as specialty referral in clinical assessment
• Formulate strategies to optimize multidisciplinary communication and specialty referral
• Incorporate updates in clinical data to inform the identification of AD early in the disease process
• Implement shared decision-making (SDM) approaches to facilitate diagnosis and optimize management

TARGET AUDIENCE

This activity is designed to meet the educational needs of healthcare providers involved in the diagnosis and continued care of patients with Alzheimer’s disease, including neurologists, geriatricians, psychiatrists, primary care physicians, nurses, and other multidisciplinary team members.

JOINT ACCREDITATION STATEMENT

In support of improving patient care, Med Learning Group is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

PHYSICIAN CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits^TM. Physicians should claim only the credit commensurate with the extent of their participation in this live activity.

NURSES (ANCC) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 2.0 ANCC contact hours.

COMMISSION ON DIETETIC REGISTRATION (CDR) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 2.0 CPEU.

PHARMACISTS and PHARMACY TECHNICIANS (ACPE) CREDIT DESIGNATION

Med Learning Group designates this activity for a maximum of 2.0 knowledge-based CPE contact hours.

NOTE to Pharmacists: The only official Statement of Credit is the one you pull from CPE Monitor. You must request your certificate within 45 days of your participation in the activity to meet the deadline for submission to CPE Monitor. Credits are generally reported during the first week of each month for those who claimed during the month prior.

 DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in an MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CE activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

During this lecture, the faculty may mention the use of medications for both FDA-approved and non-approved indications.

DISCLAIMER

Med Learning Group makes every effort to develop CE activities that are science based. This activity is designed for educational purposes. Participants have a responsibility to use this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making expertise before applying any information, whether provided here or by others, for any professional use.

For CE questions, please contact Med Learning Group at [email protected]

Contact this CE provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT 

Event Staff will be glad to assist you with any special needs (eg, physical, dietary, etc).  Please contact Med Learning Group prior to the live event at [email protected]